Mrs. Eric D Whitman, MD through @Letterkandy expresses our memories of that horrible day 13 yrs ago ow.ly/Bnq9M #notmelanoma

Cobimetinib w/Zelboraf likely next FDA approved combo for #BRAF mutated #melanoma, results at #ESMO14 9-29 ow.ly/BEP9d

If ultimate endpoint w targeted #melanoma Rx is progression then strategies should focus on getting MORE TIME ow.ly/CwKKH

Even with new drugs, almost 50% of pts will fail RX; still HUGE unmet medical need in metastatic #melanoma ow.ly/Efi1t

Even “thin” #melanoma can be fatal; points out need for better measurement than thickness #notthewholestory ow.ly/Efiu6

Another checkpoint inhibitor that interestingly doesn’t (?yet) seem to be effective against #melanoma ow.ly/EfrcM

Why do some people with #melanoma respond to #yervoy while others don’t? Starting to approach the answer: ow.ly/EJ78f

#Yervoy to treat #uveal #melanoma shows very interesting results, given lack of other successful therapies ow.ly/FlUng

BIG NEWS! #Opdivo, $bmy anti PD-1, now approved to Rx #melanoma. Same indication and limits as #keytruda ow.ly/GjXEF

#Opdivo: Seventh new drug FDA approved for #melanoma since 2011 #unbelievable ow.ly/GjXP9

New personalized #melanoma vaccine being evaluated in adjuvant Stage 3/4 setting. ow.ly/GpGsZ

Predictable combo RX trial with T-VEC and #keytruda in advanced #melanoma -- can T-VEC augment anti-PD1? ow.ly/GpI8k

A new way to counteract resistance to #BRAF inhibitors under investigation in #melanoma ow.ly/GpIjh

Another effort to predict #melanoma response to #immunotherapy #keytruda ow.ly/GM7eT

Melanovus (PSU IP--Go Lions!) assets sold to Cipher Pharma, hopefully speeding drug development ow.ly/H8WEC #melanoma

A must read about #immunotherapy for #melanoma and other cancers, discussed at ow.ly/LmUPf

#FDA combined #ODAC panel votes 22-1 in favor of #TVec approval. Fills a clinical need and combo possibilities exciting #melanoma $amgn

RT Eric D Whitman, MD: Exciting breaking news segment highlighting #AACR15, featuring .... me. ow.ly/2bsHP0 via OncLive.com

Official release by $BMY on #opdivo/#yervoy #fda approval for BRAF wt #melanoma pts. Very exciting. ow.ly/2bvxFT

To the followers of @melanoma_drs: our multiple doctors now each have their own twitter handles. Therefore, it is with some regret that we plan to shut down this account. Please follow Eric D Whitman, MD or Omid Hamid MD or Richard D Carvajal for ongoing melanoma talk and info!